Page last updated: 2024-08-17

cycloheximide and Granulocytic Leukemia, Chronic

cycloheximide has been researched along with Granulocytic Leukemia, Chronic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's7 (77.78)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, MF; Mai, WY1
Belloc, F; Bernard, P; Boisseau, MR; Dumain, P; Lacombe, F; Lopez, F; Reiffers, J1
Lotem, J; Sachs, L1
Herwig, S; Ma, Y; Su, Q; Tempst, P; Zhang, W1
Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG1
Ezawa, H; Harigaya, K; Ishii, G; Mikata, A; Nakajima, N1
Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K1
Shionoya, S1
Bankhurst, AD; Cutts, JL; Scallen, TJ; Watson, J1

Other Studies

9 other study(ies) available for cycloheximide and Granulocytic Leukemia, Chronic

ArticleYear
Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
    Chinese medical journal, 2005, Mar-20, Volume: 118, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cycloheximide; Dactinomycin; G1 Phase; Harringtonines; Homoharringtonine; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive

2005
The labelling of proliferating cells by Ki67 and MIB-1 antibodies depends on the binding of a nuclear protein to the DNA.
    Experimental cell research, 1994, Volume: 210, Issue:2

    Topics: Antibodies; Cell Line; Cycloheximide; DNA, Neoplasm; Flow Cytometry; Gene Expression; Humans; Immunoblotting; Ki-67 Antigen; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Proteins; Nuclear Proteins; Nucleic Acid Conformation; Protein Conformation; Tumor Cells, Cultured

1994
Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1993, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cycloheximide; Drug Resistance; Genes, myc; Hot Temperature; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; RNA, Messenger; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1993
Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
    Blood, 1996, Jan-01, Volume: 87, Issue:1

    Topics: Acetamides; Biomarkers; Blood Proteins; Cell Differentiation; Cycloheximide; Cytokines; Dactinomycin; Defensins; Dimethyl Sulfoxide; Dimethylformamide; DNA, Complementary; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Genistein; Granulocyte Colony-Stimulating Factor; Granulocytes; HL-60 Cells; Humans; Interferon-gamma; Isoflavones; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Recombinant Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
    Blood, 1996, Feb-01, Volume: 87, Issue:3

    Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1996
12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562.
    Hematological oncology, 1997, Volume: 15, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, Neoplasm; Blast Crisis; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Half-Life; Humans; Ki-1 Antigen; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nucleic Acid Synthesis Inhibitors; Protein Kinase C; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1997
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
    Experimental cell research, 1992, Volume: 203, Issue:1

    Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1992
Etoposide inhibition of methylaminoisobutyric acid transport and its recovery in K562 cells.
    Leukemia research, 1991, Volume: 15, Issue:2-3

    Topics: Aminoisobutyric Acids; Biological Transport; Cell Division; Cycloheximide; Depression, Chemical; Etoposide; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Sodium; Tumor Cells, Cultured; Tumor Stem Cell Assay

1991
Role of mevalonic acid in the regulation of natural killer cell cytotoxicity.
    Journal of cellular physiology, 1989, Volume: 139, Issue:3

    Topics: Cell Line; Cell Survival; Cells, Cultured; Cholesterol; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; Dolichols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lovastatin; Mevalonic Acid; Sterols

1989